Block & Leviton is investigating Stryker Corporation for potentially violating securities laws by allegedly misrepresenting the status of a manufacturing problem affecting its peripheral vascular business. Stryker's CEO initially claimed the issue was resolved in Q3 2026, but the CFO later revealed it persisted into Q4, causing the stock to drop about 8%. The investigation aims to determine if Stryker misled investors about its business health. Investors who suffered losses may be eligible to recover funds and are encouraged to contact Block & Leviton for assistance.
As of Oct 03, 2026 03:21 WIB, Stryker Corporation (SYK) trades at USD 274.87 on Pluang, just above its 52-week low of USD 269.75 and well below its 52-week high of USD 388.35. Despite the recent stock drop mentioned in the news, SYK's price shows a modest 1-day gain of 0.67%, with investors on Pluang fully buying the stock and holding it typically for 21 days. The dividend yield stands at 1.28%, reflecting some income potential amid the ongoing investigation.
